Learn how to buy shares of DBV Technologies (DBVA.F) – Tutorial in english

dbv technologies

DBV Technologies SA, a clinical stage biopharmaceutical company, is engaged in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed a Phase III clinical trial for the treatment of peanut allergies in children, adolescents and adults 4 to 11 years of age. The company is also developing Viaskin Milk, which is in a Phase I/II clinical trial for the treatment of immunoglobulin E (IgE)-mediated cow’s milk protein allergy (CMPA) and IgE-induced eosinophilic esophagitis. the milk; Viaskin Egg, a preclinical-stage product for the treatment of chicken egg allergy; and booster vaccine for Bordetella pertussis. His other early-stage research programs include a vaccine for respiratory syncytial virus, as well as treatments for Crohn’s disease. celiac disease and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE-mediated CMPA in infants and young children. DBV Technologies SA was founded in 2002 and is headquartered in Montrouge, France.

Learn how to buy shares of DBV Technologies (DBVA.F) – Tutorial in Spanish

Would you like to buy shares of DBV Technologies (DBVA.F) in Frankfurt in Spain and using a regulated broker in Europe? Are you interested in being able to monetize your earnings for the month and make profits on the stock market? In this tutorial I am going to show you how you can create a degiro account , a reliable investment platform and minimum commissions, and how you will be able to get hold of your first share of the company DBV Technologies SA (DBVA.F) ( DBVA.F) quickly and intuitively.

What we will do is very simple :

  • To begin with, we are going to register with degiro, a platform where we will buy shares of DBV Technologies SA (DBVA.F) – (DBVA.F).
  • Secondly, we will make a transfer of funds and be able to make our first investment in Degiro.
  • When we see the funds in our account, what we are going to do is locate DBV Technologies through its ticker, which is DBVA.F.
  • Finally, we will only add the number of shares we want, the purchase value and the type of order.

This summary may have been a bit short for you, so I’m going to show you the process with screenshots.

How to open a debit account

The first step is to register with DEGIRO through this link :

buy shares of DBV Technologies SA (DBVA.F)

It will ask us for an email, a username and a password to enter, and then we must continue from the link that they have sent us by email.

Soon DeGiro is going to require some essential information from us in order to verify our identity card . We must have in hand our passport number, DNI (identity document) or driving document, mobile phone and the number of the bank account that we will place to make our first deposit. If you do not know what method this format is, you can review this simple tutorial article that we have prepared .

Stock DBV Technologies

Once our account has been validated, we will be able to insert money from the Enter/Extract option. We will be able to carry out a transaction that will take more or less 1-3 days, or proceed to make the deposit instantly with Sofort, a completely secure and 100% reliable payment gateway.

deposit money into DBV Technologies account

How to buy DBV Technologies (DBVA.F) shares through DEGIRO

At the time that we have the money we will have the possibility of acquiring our first share. You can select the place order button at the top right or explore in the Degiro search engine and write the ticker. In the following image you will see that I have used the Amazon ticker but in your case you must write (DBVA.F), the DBV Technologies ticker. Since we are talking about an action, we will notice that the related tickers are listed and there we will look to find DBV Technologies. The essential thing is that the ticker, the name of the action and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case DBV Technologies SA (DBVA.F) is listed on Frankfurt. This step is very important so don’t get confused.

American stock market economist DBV Technologies

At the time of placing the order we must pay special attention to the following . We will have the possibility of placing a limit or market order. Imagine that you want to get a share of DBV Technologies, but its real price is quite high. With this limit order we will put the value at which we want to carry out the operation and until there are no shares selling at that value, the acquisition of the share will not be carried out. With a market order Degiro will buy the number of shares we have proposed at the current selling price, which will be very close to the live listing price.

limit buy order DBV Technologies SA (DBVA.F)

In one case or another, it is convenient that you look at the type of number: fixed or of the day . To give an example, in Spain, the stock market is from morning until 1 in the afternoon, and in the US it corresponds to the afternoon schedule in Spain. If an order is fixed, it will last until the point where it can be executed, but if you choose the «of the day» option, at the end of the day, if it has not been executed, it will be removed from your Activity section – Pending Orders .

I would like this short text to have helped you to buy shares in DBV Technologies. Thank you very much.

  Company information
  • DBV Technologies SA (DBVA.F) address: 177-181 Avenue Pierre Brossolette Montrouge 92120 France 33 1 55 42 78 78 – Website: http://www.dbv-technologies.com
  • Ticker: DBVA.F
  • Sector: Health
  • Industry: Employees
  • Number of employees: 97
  • Listed market: Frankfurt

key executives

Name Title Salary exercised Year of birth
Mr. Daniel Tasse CEO and Director 1.1 million N/A 1960
Mr. Sébastien Robitaille CFO 291.82k N/A 1970
Dr Pharis Mohideen Medical director 625.26k N/A 1965
Dr Pierre-Henri Benhamou Co-Founder and Member of the Scientific Advisory Board N/A N/A 1955
Mr Pascal Wotling Director of Technical Operations N/A N/A N/A
Anne Pollak Head of Investor Relations N/A N/A N/A
Mrs. Michele F. Robertson Counsel N/A N/A N/A
Joseph Becker Vice President of Global Corporate Communications N/A N/A N/A
Mrs Caroline Daniere Human Resources Director and Chief of Staff N/A N/A 1975
Dr. Wence Agbotounou Director of Clinical Trials and Senior Vice President N/A N/A N/A

Recent events of :

We have no recent events for this company.